GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,588.00
Ask: 12,590.00
Change: -34.00 (-0.27%)
Spread: 2.00 (0.016%)
Open: 12,626.00
High: 12,646.00
Low: 12,474.00
Prev. Close: 12,590.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks muted as new lockdown outweighs strong business activity data

Wed, 24th Mar 2021 09:52

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* EU records strong flash PMIs, consumer confidence improves

* EU to extend vaccine export curbs

* Chip stocks jump on Intel's spending plan
(Adds comments, updates prices throughout)

By Sruthi Shankar and Shreyashi Sanyal

March 24 (Reuters) - European stocks were subdued on
Wednesday, as concerns about new lockdown measures overshadowed
a surprise return to economic growth for the euro zone in March.

After falling as much as 0.7% in earlier in the day, the
pan-European STOXX 600 index ended flat.

Euro zone stocks also cut losses after IHS
Markit's flash composite PMI, seen as a good guide to economic
health, bounced above the 50 mark, separating growth from
contraction, to 52.5 this month compared with February's 48.8.

While the data gave investors some relief, a third wave of
coronavirus infections and renewed lockdown measures in Europe,
as well as a slow vaccine roll-out are likely to weigh on the
final reading of the survey and April's numbers.

"We believe this is a pause, not the end of the equity rally
yet," said Michele Morganti, an equity strategist at Generali
Insurance Asset Management.

"COVID management is a bumpy road. We nevertheless think
that recovery will be quite strong in the second half of the
year."

Another piece of data showed a flash estimate of euro zone
consumer morale improved to -10.8 this month from -14.8 in
February.

"The sharp increase in euro zone consumer confidence in
March came as a big surprise given tighter restrictions across
the bloc and ongoing difficulties with the AstraZeneca vaccine,"
said Melanie Debono, Europe economist at Capital Economics.

The European stocks benchmark has pulled away from a
one-year peak hit last week after major economies like Germany
and France imposed new lockdowns.

Meanwhile, the European Union is set to extend COVID-19
vaccine export curbs to Britain and other areas with much higher
vaccination rates, and to cover instances of companies
backloading contracted supplies, EU officials said.

Among individual stocks, Italian defence and aerospace group
Leonardo fell -6.1% after it postponed the initial
public offering of its U.S. electronics unit DRS

Commerzbank rose 1.6% even as Germany's No. 2
lender said it expects a net loss for 2021.

Big gains for chipmakers helped limit market losses.

Shares in ASM International, ASML and
Infineon Technologies, were up between 0.3% and 5.2%
after U.S. firm Intel Corp announced a $20 billion plan
to expand its advanced chip manufacturing capacity.

French supermarket retailer Carrefour rose 2.3%
after saying it had agreed to buy Brazil's third biggest food
retailer Grupo BIG in a deal that values it at $1.3 billion.
(Reporting by Sruthi Shankar and Shreyashi Sanyal in Bengaluru;
Editing by Arun Koyyur)

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the European Union.

Read more
3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.

Read more
2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of the mutant protein targeted by the drug, according to trial results announced on Sunday.

Read more
2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by about five months for people with low levels of HER2 protein whose cancer progressed following endocrine therapy, according to research presented on Sunday.

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.